SCD5 and HIV-1 infection: In contrast, sCD4–183, a small gp120-neutralizing reagent (26kD) was able to equally inhibit all three modes of infection, namely cell free, IFN-α-DC-mediated and LPS-DC-mediated HIV-1 infection of CD4+ T cells (Fig. 6G).